Skip to main content
SpringerLink
Log in

Treatment of Limited-Stage Small Cell Lung Cancer

  • Chapter
Lung Cancer

Part of the book series: M.D. Anderson Cancer Care Series ((MDCCS))

  • 253 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  • Aisner SC, Finkelstein DM, Ettinger DS, et al. The clinical significance of variantmorphology small-cell carcinoma of the lung. J Clin Oncol 1990;8:402–408.

    CAS  PubMed  Google Scholar 

  • Ariyoshi Y, Fukuoka M, Furuse K, et al. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Jpn J Clin Oncol 1994;24:275–281.

    CAS  PubMed  Google Scholar 

  • Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848–1852.

    Article  CAS  PubMed  Google Scholar 

  • Arriagada R, Le Chevalier T, Ruffie P, et al. Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center’s Lung Group. Int J Radiat Oncol Biol Phys 1990;19:1135–1138.

    CAS  PubMed  Google Scholar 

  • Arriagada R, Pellae-Cosset B, Cueto Ladron de Guevara JC, et al. Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiother Oncol 1991;20:91–98.

    Article  CAS  PubMed  Google Scholar 

  • Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476–484.

    Article  CAS  PubMed  Google Scholar 

  • Bunn PA, Ihde DC. Small cell bronchogenic carcinoma: a review of therapeutic results. In: Livingston RB, ed. Lung Cancer. Vol 1. Boston, Mass: Nijhoff; 1981:169–208.

    Google Scholar 

  • Carney DN. Lung cancer biology. Semin Radiat Oncol 1995;5:4–10.

    PubMed  Google Scholar 

  • Choi NC, Herndon JE II, Rosenman J, et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 1998;6:3528–3536.

    Google Scholar 

  • Cox JD. Dose-response in small cell carcinoma [editorial]. Int J Radiat Oncol Biol Phys 1988;14:393–394.

    CAS  PubMed  Google Scholar 

  • Cox JD, Komaki R, Byhardt RW, et al. Results of whole-brain irradiation for metastases from small cell carcinoma of the lung. Cancer Treatment Reports 1980;64:957–961.

    CAS  PubMed  Google Scholar 

  • Coy P, Hodson I, Payne DG, et al. The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter randomized trial. Int J Radiat Oncol Biol Phys 1988;14:219–226.

    CAS  PubMed  Google Scholar 

  • Cull A, Gregor A, Hopwood P, et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer [abstract]. Eur J Cancer 1994;30A(8):1067–1074.

    Article  CAS  PubMed  Google Scholar 

  • Ettinger DS, Seiferheld WF, Abrams RA, et al. Cisplatin (P), etoposide (E), paclitaxel (T), and concurrent hyperfractionated thoracic radiotherapy (TRT) for patients (Pts) with limited disease (LD) small cell lung cancer (SCLC): preliminary results of RTOG 96-09 [abstract]. Proc Am Soc Clin Oncol 2000;19:490a.

    Google Scholar 

  • Feld R, Ginsberg RJ, Payne DG. Treatment of small cell lung cancer. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. Thoracic Oncology. Philadelphia, PA: Saunders; 1993:229–262.

    Google Scholar 

  • Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973;2(7820):63–65.

    Article  CAS  PubMed  Google Scholar 

  • Glisson B, Scott C, Komaki R, et al. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of Radiation Therapy Oncology Group trial 93-12. J Clin Oncol 2000;18:2990–2995.

    CAS  PubMed  Google Scholar 

  • Goto K, Nishiwaki Y, Takada M, et al. Final results of a phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC): the Japan Clinical Oncology Group (JCOG) study [abstract]. Proc Am Soc Clin Oncol 1999;18:A1805. Abstract 468a.

    Google Scholar 

  • Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15–36.

    Article  CAS  PubMed  Google Scholar 

  • Hainsworth JD, Gray JR, Stroup SL, et al. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities. J Clin Oncol 1997;15:3464–3470.

    CAS  PubMed  Google Scholar 

  • Janaki L, Rector D, Turrisi A, et al. Patterns of failure and second malignancies from SWOG-8629: concurrent cisplatin, etoposide, vincristine, and once daily radiotherapy for the treatment of limited small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1994;13:331.

    Google Scholar 

  • Johnson RE, Brereton HD, Kent CH. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet 1976;2(7980):289–291.

    Article  CAS  PubMed  Google Scholar 

  • Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 1996;14:806–813.

    CAS  PubMed  Google Scholar 

  • Johnson BE, Salem C, Nesbitt J, et al. Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 1993;9(suppl 1):S21–S26.

    Article  Google Scholar 

  • Kies MS, Mira JG, Crowley JJ, et al. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group study. J Clin Oncol 1987;5:592–600.

    CAS  PubMed  Google Scholar 

  • Komaki R, Byhardt RW, Anderson T, et al. What is the lowest effective biologic dose for prophylactic cranial irradiation? Am J Clin Oncol 1985;8:523–527.

    CAS  PubMed  Google Scholar 

  • Komaki R, Cox JD, Whitson W. Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treatment Reports 1981;65:811–814.

    CAS  PubMed  Google Scholar 

  • Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995a;33:179–182.

    Article  CAS  PubMed  Google Scholar 

  • Komaki R, Milas L, Glisson B, et al. Effect of duration of thoracic radiation therapy (TRT) on the outcome of patients with limited small cell lung cancer (LSCLC) treated with chemotherapy and radiation therapy [abstract]. Radiother Oncol 2000;56:S57.

    Google Scholar 

  • Komaki R, Shin DM, Glisson BS, et al. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1995b;31:807–811.

    Article  CAS  PubMed  Google Scholar 

  • Liengswangwong V, Bonner JA, Shaw EG, et al. Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 1994;12:496–502.

    CAS  PubMed  Google Scholar 

  • Looney WB. The experimental basis of new strategies in combining chemotherapy and radiotherapy. In: Horwich A, ed. Combined Radiotherapy and Chemotherapy in Clinical Oncology. London: Edward Arnold; 1992:23–33.

    Google Scholar 

  • McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group study. J Clin Oncol 1990;8:892–898.

    CAS  PubMed  Google Scholar 

  • Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336–344.

    CAS  PubMed  Google Scholar 

  • National Comprehensive Cancer Network. Oncology Practice Guidelines. Small cell lung cancer. Oncology (suppl) 1996;10:179–194.

    Google Scholar 

  • Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85–91.

    Article  CAS  PubMed  Google Scholar 

  • Nugent JL, Bunn PA Jr, Matthews MJ, et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979;44:1885–1893.

    CAS  PubMed  Google Scholar 

  • Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254–261.

    Article  CAS  PubMed  Google Scholar 

  • Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618–1624.

    Article  CAS  PubMed  Google Scholar 

  • Shaw E, Su J, Eagan R, et al. Analysis of long-term survival and impact of prophylactic cranial irradiation in complete responders with small cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. Proc Am Soc Clin Oncol 1993;12:328.

    Google Scholar 

  • Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996;14:821–828.

    CAS  PubMed  Google Scholar 

  • Stahel RA, Weber E. Small cell lung cancer: the new biology. Semin Radiat Oncol 1995;5:11–18.

    PubMed  Google Scholar 

  • Turrisi AT, Glover DJ, Mason B, et al. Long-term results of platinum, etoposide and twice daily thoracic radiotherapy for limited small cell lung cancer: results on 32 patients with 48 month minimum follow-up [abstract]. Proc Am Soc Clin Oncol 1992;11:292.

    Google Scholar 

  • Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265–271.

    Article  CAS  PubMed  Google Scholar 

  • Wagner H, Kim K, Johnson DH, et al. Daily vs. twice-daily thoracic irradiation with concurrent cisplatin/etoposide chemotherapy as initial therapy for patients with limited small cell lung cancer: preliminary results of a phase III prospective intergroup trial. Int J Radiat Oncol Biol Phys 1994;30(suppl 1):178.

    Google Scholar 

  • Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890–895.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Ritsuko Komaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Frank V. Fossella MD

  2. Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Ritsuko Komaki MD

  3. Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Joe B. Putnam Jr. MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Komaki, R. (2003). Treatment of Limited-Stage Small Cell Lung Cancer. In: Fossella, F.V., Komaki, R., Putnam, J.B. (eds) Lung Cancer. M.D. Anderson Cancer Care Series. Springer, New York, NY. https://doi.org/10.1007/0-387-22652-4_10

Download citation

  • DOI: https://doi.org/10.1007/0-387-22652-4_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95507-0

  • Online ISBN: 978-0-387-22652-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation